Angiotensin II-induced hypertension accelerates the development of atherosclerosis in ApoE-deficient mice

Circulation

Volumn 103, Issue 3, 2001, Pages 448-454

  Weiss, Daiana ^a   Kools, John J ^a   Taylor, W Robert ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin; Apolipoproteins; Atherosclerosis; Hypertension

Indexed keywords

ANGIOTENSIN; APOLIPOPROTEIN E;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROGENIC DIET; ATHEROSCLEROSIS; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; HISTOPATHOLOGY; HYPERLIPOPROTEINEMIA TYPE 3; HYPERTENSION; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; THORACIC AORTA;

EID: 0035936487     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.103.3.448     Document Type: Article

References (43)

1. Pathogenesis and prevalence of atherosclerosis in hypertensive patients
2. Hypertension and pathogenesis of atherosclerosis: Oxidative stress and the mediation of arterial inflammatory response
3. Study of stress concentration in the walls of the bovine coronary arterial branch
4. Pressure-induced arterial wall stress and atherosclerosis
5. Mechanical deformation of the arterial wall in hypertension: A mechanism for vascular pathology
6. Cyclic strain induces an oxidative stress in endothelial cells
7. Pulsatile stretch stimulates superoxide production and activates nuclear factor-KB in human coronary smooth muscle
8. Cyclic strain-induced monocyte chemotactic protein-1 gene expression in endothelial cells involves reactive oxygen species activation of activator protein 1
9. Mechanical strain induces monocyte chemotactic protein-1 expression in endothelial cells
10. Monocyte chemoattractant protein-1 expression in aortic tissues of hypertensive rats
11. Inhibition of atherosclerosis associated with reduction of arterial intramural stress in rabbits
12. Angiotensin, other pressors, and the transduction of vascular smooth muscle contraction
13. Cellular mechanisms of angiotensin II action
14. Oxidative Stress and cardiovascular disease
15. Angiotensin II signaling in vascular smooth muscle: New concepts
16. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells
17. Atherosclerosis-an inflammatory disease
18. The angiotensin-II receptor antagonist, losartan, inhibits LDL lipid peroxidation and atherosclerosis in apolipoprotein E-deficient mice
19. Inhibitors of angiotensin converting enzyme decrease early atherosclerosis in hyperlipidemic hamsters: Fosinopril reduces plasma cholesterol and captopril inhibits macrophage-foam cell accumulation independently of blood pressure and plasma lipids
20. 1-Adrenergic plus angiotensin receptor blockade reduces atherosclerosis in apolipoprotein E-deficient mice
21. Differential effects of reninangiotensin system blockade on atherogenesis in cholesterol-fed rabbits
22. Is there a link between the circulating renin-angiotensin system and coronary disease? A buoyant view
23. Plasma renin activity: A risk factor for myocardial infarction in hypertensive patients
24. Plasma renin activity and ischemic heart disease
25. The epidemiology of plasma renin
26. Effects of an angiotensin-converting enzyme inhibitor, Ramapril, on cardiovascular events in high risk patients: The Heart Outcomes Prevention Evaluation Study investigators
27. Variation in susceptibility to atherosclerosis among inbred strains of mice
28. A noninvasive computerized tail-cuff system for measuring blood pressure in mice
29. Quantitation of atherosclerosis in murine models: Correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice
30. ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis: Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum
31. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree
32. Association of the reninsodium profile with the risk of myocardial infarction in patients with hypertension
33. Angiotensin II administration as an experimental model of hypertension
34. 2 in angiotensin II-induced vascular hypertrophy
35. Angiotensin induces inflammatory activation of human vascular smooth muscle cells
36. Vascular thrombin receptor regulation in hypertensive rats
37. Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells
38. Increase of vitamin E content in LDL and reduction of atherosclerosis in cholesterol-fed rabbits by a water-soluble antioxidant-rich fraction of Salvia miltiorrhiza
39. Vitamin E combined with selenium inhibits atherosclerosis in hypercholesterolemic rabbits independently of effects on plasma cholesterol concentrations
40. Antioxidant effects of lovastatin and vitamin E on experimental atherosclerosis in rabbits
41. Vascular cell-adhesion molecule-1 (VCAM-1) gene-transcription and expression are regulated through an antioxidant sensitive mechanism in human vascular endothelial cells
42. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice
43. Established risk factors and coronary artery disease: The Framingham Study